Polyphenols comprise a large group of plant secondary metabolites that have been associated with numerous beneficial effects to promote and maintain health and thereby prevent the onset of a number of diseases such as diabetes, cardiovascular disease and cancer.(Reference Zhang and Tsao1, Reference Croft2). The detailed mechanisms by which polyphenols act on a cellular level are still largely unknown. It has recently been suggested that some members of the flavonoid subgroup of polyphenols, might have the ability to act as ligands for nuclear receptors and thereby impact on transcriptional regulation of metabolic pathways, such as cell development, energy metabolism and inflammation(Reference Avior, Bomze, Ramon and Nahmias3). The aim of this study was to investigate the effects of different polyphenols on activation of the nuclear receptor LXRα. LXRα is the primary regulator of cholesterol and fatty acid metabolism. Activation of LXRα also inhibits pro-inflammatory gene expression(Reference Viennois4).
Human breast cancer cells, stably transfected with LXRα/luciferase reporter, were incubated with the polyphenols hesperetin (flavanone), quercetin and isorhamnetin (flavonol), resveratrol (stilbene), genistein (isoflavone), epigallocatechin gallate (flavanol) in increasing concentrations (5–50μM) and T0901417 (1μM) as positive control for 16 hours. LXRα activation was assessed using luciferase assay and normalised to total cell protein measured using BCA assay. The neutral red assay was conducted to evaluate cytotoxicity of polyphenols. Data were analyzed using one way ANOVA followed by Dunnett's posthoc test.
Hesperetin, quercetin, isorhamnetin, resveratrol, and genistein demonstrate capacity to activate LXRα albeit to a differing degree with genistein providing most consistent activation as indicated in Fig 1. EGCG showed very weak LXRα activation. None of the test compounds and solvent caused cytotoxicity (viability >80 %) in the concentrations applied (data not shown).
Our results indicate that polyphenols belonging to different subclasses can activate LXRα and further studies are needed to demonstrate effects on LXRα target gene expression and metabolic changes including application in more relevant cell types such as liver cells.